Venus Remedies Ltd
NSE:VENUSREM
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Venus Remedies Ltd
Cash from Operating Activities
Venus Remedies Ltd
Cash from Operating Activities Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cash from Operating Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Venus Remedies Ltd
NSE:VENUSREM
|
Cash from Operating Activities
₹1.4B
|
CAGR 3-Years
63%
|
CAGR 5-Years
3%
|
CAGR 10-Years
N/A
|
|
|
Dr Reddy's Laboratories Ltd
NSE:DRREDDY
|
Cash from Operating Activities
₹58.8B
|
CAGR 3-Years
12%
|
CAGR 5-Years
14%
|
CAGR 10-Years
N/A
|
|
|
Cipla Ltd
NSE:CIPLA
|
Cash from Operating Activities
₹42.9B
|
CAGR 3-Years
14%
|
CAGR 5-Years
6%
|
CAGR 10-Years
N/A
|
|
|
Sun Pharmaceutical Industries Ltd
NSE:SUNPHARMA
|
Cash from Operating Activities
₹127.2B
|
CAGR 3-Years
46%
|
CAGR 5-Years
22%
|
CAGR 10-Years
N/A
|
|
|
Lupin Ltd
NSE:LUPIN
|
Cash from Operating Activities
₹47.3B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
146%
|
CAGR 10-Years
N/A
|
|
|
T
|
Torrent Pharmaceuticals Ltd
NSE:TORNTPHARM
|
Cash from Operating Activities
₹19.4B
|
CAGR 3-Years
0%
|
CAGR 5-Years
1%
|
CAGR 10-Years
N/A
|
|
Venus Remedies Ltd
Glance View
Venus Remedies Ltd. engages in the manufacture and trade of pharmaceutical products. The company is headquartered in Panchkula, Haryana. The firm operates in Pharmaceutical Formulation segment. The firm is engaged in manufacturing and trading of medicines. The company manufactures products catering to critical care segments, such as anticancer, anti-infective, neurology, skin and wound care, and pain management. The Company’s brands include Supime, Clindol, Pisa, Ronem, Megaparin and Coguperin. The company has its manufacturing facilities in Panchkula and Baddi (in India) and Werne (in Germany) and a research and development center in Venus Medicine Research Center (in India). The firm has its presence in approximately 75 companies. The Company’s wholly owned subsidiary is Venus Pharma GmbH, which deals in licensing, packaging, product testing, warehousing and logistics.
See Also
What is Venus Remedies Ltd's Cash from Operating Activities?
Cash from Operating Activities
1.4B
INR
Based on the financial report for Dec 31, 2025, Venus Remedies Ltd's Cash from Operating Activities amounts to 1.4B INR.
What is Venus Remedies Ltd's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 5Y
3%
Over the last year, the Cash from Operating Activities growth was 117%. The average annual Cash from Operating Activities growth rates for Venus Remedies Ltd have been 63% over the past three years , 3% over the past five years .
